➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Colorcon
McKinsey
Mallinckrodt
Moodys
Dow

Last Updated: September 23, 2020

DrugPatentWatch Database Preview

Claims for Patent: 6,406,897

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 6,406,897
Title: Modified protein, method for preparation thereof and compositions for external application containing the modified protein
Abstract:A protein modified to improve its stability, said modified protein being coupled to a .beta.-1,3-glucan branched with .beta.-1,6-linkage is provided. A method for the production thereof and a cosmetic or dermatological composition comprising the modified protein are also provided. The modified protein shows an improved stability while retaining its activity and being free of skin irritation.
Inventor(s): Kim; Mu Sung (Suwon, KR), Lee; Sung Gu (Suwon, KR), Kang; Byung Young (Seoul, KR), Lee; Dong Chul (Sungnam, KR)
Assignee: Pacific Corporation (Seoul, KR)
Application Number:09/453,965
Patent Claims:1. A protein modified to improve its stability, said modified protein being coupled to a .beta.-1,3-glucan branched with .beta.-1,6-linkage, wherein said .beta.-1,3-glucan comprises one .beta.-1,6-linkage for every three .beta.-1,3-main chains.

2. The modified protein of claim 1, wherein said .beta.-1,3-glucan branched with .beta.-1,6-linkage is schizophyllan or scleroglucan.

3. The modified protein of claim 1, wherein said protein is selected from the group consisting of papain, bromelain, ficin, trypsin, chymotrypsin, collagenase, elastase, plasmin, bacterial protease, .alpha.-amylase, glucoamylase, cellulase, pectinase, xylanase, .alpha.-glucosidase, .beta.-glucosidase, .alpha.-galactosidase, .beta.-galactosidase, .beta.-glucanase, chitinase, mannanase, phospholipase, triacylglycerol hydrolase, DNase, RNase, phosphatases, lysozymes, catalases, superoxide dismutases, transglutamninases, peroxidases, photolyases, cytokines, growth factors, hormones, immunoglobulins, lactoferrins, metallothioneins and thioredoxins.

4. A method for modifying protein to improve its stability which comprises the step of coupling the protein to a .beta.-1,3-glucan branched with .beta.-1,6-linkage, wherein said .beta.-1,3-glucan comprises one .beta.-1,6-linkage for every three .beta.-1,3-main chains.

5. A method of claim 4, wherein the coupling comprises the steps of

(a) reacting said glucan with periodates to oxidize .beta.-1,6-residues of the glucan to form aldehydes;

(b) removing unreacted periodates from the reaction solution;

(c) adding to the reaction solution a protein in an amount of 0.00001.about.10.0% by weight and allowing the protein to react with the oxidized glucan; and

(d) adding to the reaction solution a reducing agent in an amount of 0.0001.about.1.0% by weight.

6. A method of claim 5, which further comprises the step of (e) washing the product in the step (d).

7. A method of claim 5, wherein, when two or more proteins are modified a first protein is added to the reaction mixture in the step (c) and proteins are added to the reaction mixture in the step (d), wherein not all of the aldehydes formed in step (a) react with the first protein in step (c).

8. A method of claim 4, wherein said protein is selected from the group consisting of papain, bromelain, ficin, trypsin, chymotrypsin, collagenase, elastase, plasmin, bacterial protease, .alpha.-amylase, glucoamylase, cellulase, pectinase, xylanase, .alpha.-glucosidase, .beta.-glucosidase, .alpha.-galactosidase, .beta.-galactosidase, .beta.-glucanase, chitinase, mannanase, phospholipase, triacylglycerol hydrolase, DNase, RNase, phosphatases, lysozymes, catalases, superoxide dismutases, transglutamninases, peroxidases, photolyases, cytokines, growth factors, hormones, immunoglobulins, lactoferrins, metallothioneins and thioredoxins.

9. A method of claim 4, wherein said .beta.-1,3-glucan branched with .beta.-1,6 linkage is schizophyllan or scleroglucan.

10. A method of claim 9 wherein said .beta.-1,3-glucan branched with .beta.-1,6-linkage is one of those subjected to the molecular weight adjustment using a microfluidizer, sonicator or .beta.-1,3-glucanase.

11. A composition for external or topical application which comprises the modified protein of claim 1 in an amount of 0.00001.about.100% by weight based on the total weight of the composition and a dermatologically or cosmetically acceptable vehicle.

12. A composition of claim 11, which is a cosmetic composition selected from the group consisting of cleansing lotion, cleansing cream, skin milk, emollient lotion, massage cream, emollient cream, make-up base, lipstick, facial pack, facial gel, shampoos, rinses, hair-tonics and soaps.

13. A composition of claim 11, which is a dermatological composition selected from the group consisting of lotions, ointments, gels, creams, patches and sprays.

Summary for Patent:   Start Trial

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
South Korea99-9380Mar 19, 1999

Details for Patent 6,406,897

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Smith And Nephew SANTYL collagenase OINTMENT;TOPICAL 101995 001 1965-06-04   Start Trial Pacific Corporation (Seoul, KR) 2019-03-19 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Medtronic
Baxter
Harvard Business School
Johnson and Johnson
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.